Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125243541 | 12524354 | 1 | I | 20160627 | 20160704 | 20160704 | EXP | US-STRIDES ARCOLAB LIMITED-2016SP008691 | STRIDES | QURESHI M, CATALASAN G. THE USE OF HIGH DOSE INSULIN EUGLYCEMIA THERAPY IN CALCIUM CHANNEL BLOCKER AND BETA BLOCKER OVERDOSE. J-GEN-INTERN-MED. 2016;31 (SUPPL.1)(2):S760-S761 | 0.00 | Y | 0.00000 | 20160704 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125243541 | 12524354 | 1 | PS | Hydralazine HCL | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 200770 | |||||||||||
| 125243541 | 12524354 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 125243541 | 12524354 | 3 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 125243541 | 12524354 | 4 | SS | CARVEDILOL. | CARVEDILOL | 1 | UNK | 0 | |||||||||||
| 125243541 | 12524354 | 5 | SS | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | UNK | 0 | |||||||||||
| 125243541 | 12524354 | 6 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125243541 | 12524354 | 1 | Product used for unknown indication |
| 125243541 | 12524354 | 2 | Product used for unknown indication |
| 125243541 | 12524354 | 3 | Product used for unknown indication |
| 125243541 | 12524354 | 4 | Product used for unknown indication |
| 125243541 | 12524354 | 5 | Product used for unknown indication |
| 125243541 | 12524354 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125243541 | 12524354 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125243541 | 12524354 | Acute kidney injury | |
| 125243541 | 12524354 | Blood lactic acid increased | |
| 125243541 | 12524354 | Cardiomegaly | |
| 125243541 | 12524354 | Overdose | |
| 125243541 | 12524354 | Pulmonary oedema | |
| 125243541 | 12524354 | Shock | |
| 125243541 | 12524354 | Supraventricular tachycardia | |
| 125243541 | 12524354 | Troponin I increased | |
| 125243541 | 12524354 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |